Pembrolizumab shows promise as first-line treatment for advanced kidney cancer
The immune checkpoint (PD-1) inhibitor, pembrolizumab, shows promise as a [...]
The immune checkpoint (PD-1) inhibitor, pembrolizumab, shows promise as a [...]
The results from the renal cell carcinoma (RCC) group of [...]
The National Institute for Health and Care Excellence (NICE) have issued an [...]
Results from the PRINCIPAL study to evaluate the real world [...]
This interview with Dr Ramaprasad Srinivasan from the National Cancer Institute in [...]
According to the results of a recent meta-analysis of three [...]
The results from CARMENA, a randomised phase III clinical trial [...]
In this article, Dr Daniel Heng focuses on prognostic criteria [...]
This article summarises a presentation by Dr Ulka Vaishampayanon at [...]
Patient-reported outcomes data from the Phase 3 CheckMate-214 trial of [...]